Biocortech
Records under this name other than patents Biocortech holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Biocortech
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,771,953 | Evaluation of the potential risk of drug induced mood disturbance and suicide: use of a dedicated platform Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,635,558 | Method for analyzing nucleic acid and use thereof for evaluating the degree of mRNA editing of the serotonin 5-HT2C receptor Formerly held Lapsed on the fee record Ended Dec 22, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 22, 2021 | From the USPTO record |
| US 7,354,918 | Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol and applications thereof Lapsed on the fee record Ended Apr 8, 2016 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2016 | From the USPTO record |